Holdings and trades for CEO of Entrada Therapeutics
Holdings and trades for CEO of Entrada Therapeutics
Recent Insider Trades
No insider trades found for this CEO.
Nathan J. Dowden
CEO of Entrada Therapeutics
Predecessor
Dipal Doshi
March 2021 - January 2024
Successor
None